好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Poster Session 9

Thursday 04/30/09
04:00 PM - 07:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Anterior Horn, Behavioral Neurology, Epilepsy, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neuroepidemiology/Health Services and Outcomes Research
No CME available
Event Timeline
04:00 PM - 07:00 PM Abstract 001 - Changes in Mini Mental Status Examination over Time in Huntington's Disease
04:00 PM - 07:00 PM Abstract 002 - The Written and Oral Administration of the Symbol Digit Modality Test in Huntington Disease
04:00 PM - 07:00 PM Abstract 003 - Postural Limits of Stability in Presymptomatic and Symptomatic Huntington's Disease
04:00 PM - 07:00 PM Abstract 004 - Postural Control in Preclinical Huntington's Disease
04:00 PM - 07:00 PM Abstract 005 - Depression in Huntington Disease - An Under-Recognized and Under-Treated Condition
04:00 PM - 07:00 PM Abstract 006 - Longitudinal Changes in Dopaminergic Function and Regional Mechanism in Preclinical Huntington's Disease
04:00 PM - 07:00 PM Abstract 007 - Longitudinal Diffusion Tensor Imaging in Huntington's Disease
04:00 PM - 07:00 PM Abstract 008 - Puromycin-Sensitive Aminopeptidase (PSA) Reduces Aggregation Caused by Expanded Huntingtin in Cultured Cells and Is Induced in Brains of a Mouse Model of Huntington's Disease
04:00 PM - 07:00 PM Abstract 009 - Bilateral Globus Pallidus Deep Brain Stimulation for Huntington's Disease: Outcome in 8 Patients
04:00 PM - 07:00 PM Abstract 010 - Post-Ictal Improvement of a Lance-Adams Syndrome
04:00 PM - 07:00 PM Abstract 011 - Prospective Study of Infection with Epstein-Barr Virus and Risk of Developing Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 012 - Smoking, Genes and Risk for Parkinson's Disease
04:00 PM - 07:00 PM Abstract 013 - The Effect of Cigarette Smoking on Survival in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 014 - Development of an Algorithm To Identify Parkinson's Disease in the Cardiovascular Health Study
04:00 PM - 07:00 PM Abstract 015 - Incidence of Multiple Sclerosis, Myasthenia Gravis and Guillain-Barr[eacute] Syndrome in Argentina
04:00 PM - 07:00 PM Abstract 016 - Prospective Non-Motor Symptoms' Evaluation of a Cohort with Parkinson's Disease and Other Parkinsonian Disorders. The PRIAMO Study
04:00 PM - 07:00 PM Abstract 017 - The Frequency (Prevalence Rate) of Multiple Sclerosis in Iraq: A Retrospective Study
04:00 PM - 07:00 PM Abstract 018 - Population-Based Study of Baseline Ethanol Consumption and Risk of Incident Essential Tremor
04:00 PM - 07:00 PM Abstract 019 - Time to Initiation of Disease Modifying Therapy for Multiple Sclerosis Patients in a Commercial Managed Care Population
04:00 PM - 07:00 PM Abstract 020 - Mellen Center Care On-Line, a Randomized, Trial of a Tele-Medicine Intervention To Improve Patient Self-Management: Study Design and Subject Baseline Characteristics
04:00 PM - 07:00 PM Abstract 021 - Physician Perception of Acute Stroke Care in a Mexican Community
04:00 PM - 07:00 PM Abstract 022 - Impact of International Subarachnoid Aneurysm Trial Results on Treatment of Ruptured Intracranial Aneurysms in United States
04:00 PM - 07:00 PM Abstract 023 - Cost-Effectiveness Analysis of Protected Carotid-Artery Versus Endarterectomy in High Surgical Risk Patients
04:00 PM - 07:00 PM Abstract 024 - Current State of Neurohospitalist Practice
04:00 PM - 07:00 PM Abstract 025 - Utilization of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke: Exploratory Analysis of Demographic and Risk Factors
04:00 PM - 07:00 PM Abstract 026 - Secondary Prevention of Stroke after Transient Ischemic Attack - Results from the Minnesota Stroke Registry
04:00 PM - 07:00 PM Abstract 027 - Clinical Utility of Head CT for Dizziness in the Emergency Department
04:00 PM - 07:00 PM Abstract 028 - High Prevalence and Geographical Variation of Myasthenia Gravis in an Italian Area
04:00 PM - 07:00 PM Abstract 029 - The NIH Toolbox: An Instrument for Assessment of Neurological and Behavioral Function
04:00 PM - 07:00 PM Abstract 030 - Tracheostomy in ALS: A 10-Year Population-Based Study in Italy
04:00 PM - 07:00 PM Abstract 031 - Tumors Preceding ALS Onset and ALS: Results from a Case-Control Study
04:00 PM - 07:00 PM Abstract 032 - 'NEUROLINK': Improving Access to the Neurology Service in a Dublin Hospital Using Telemedicine
04:00 PM - 07:00 PM Abstract 033 - Analysis of Healthcare Costs in a Large Cohort of Patients with Myasthenia Gravis
04:00 PM - 07:00 PM Abstract 034 - Occupational Exposures and the Risk of Amyotrophic Lateral Sclerosis (ALS)
04:00 PM - 07:00 PM Abstract 035 - Accessibility of Neurological Care and Epidemiology of Neurological Disease in Ghana, West Africa
04:00 PM - 07:00 PM Abstract 036 - Brain Networks Identified by Partial Least Square Modeling Are Associated with Gait Instability in the Oldest Old
04:00 PM - 07:00 PM Abstract 037 - A Prospective Nested Case-Control Study of Organochlorine Exposures and Risk of Parkinson Disease
04:00 PM - 07:00 PM Abstract 038 - Anemia Preceding Parkinson's Disease: A Case-Control Study
04:00 PM - 07:00 PM Abstract 039 - A 15-Year Population-Based Longitudinal Study of Incidence of Parkinson's Disease (PD) and Parkinsonian Syndromes (PS) in an Elderly French Population (PAQUID)
04:00 PM - 07:00 PM Abstract 040 - Survival among Veterans with Parkinson's Disease
04:00 PM - 07:00 PM Abstract 041 - Racial Differences in Expectations Regarding Movement (ERM)
04:00 PM - 07:00 PM Abstract 042 - Correlations of Serum Uric Acid Levels with Parkinson's Disease Symptom Severity
04:00 PM - 07:00 PM Abstract 043 - Dopamine Antagonist Prescribing Practices to Persons with Parkinson's Disease (PD)
04:00 PM - 07:00 PM Abstract 044 - Nutrient Intake in Parkinson's Disease (PD) Compared to Age-Matched Controls
04:00 PM - 07:00 PM Abstract 045 - Subcortical Brain Atrophy and Mild Cognitive Impairment in Early Parkinson Disease. A Case-Control Study
04:00 PM - 07:00 PM Abstract 046 - Ethnic Variation and Geographic Distribution of Parkinson Disease in the United States
04:00 PM - 07:00 PM Abstract 047 - Juvenile-Onset Distal Hereditary Motor Neuropathy Associated with Sensorineural Hearing Loss
04:00 PM - 07:00 PM Abstract 048 - The Natural History of Progressive Bulbar Palsy
04:00 PM - 07:00 PM Abstract 049 - Retrospective Cohort Study of Hyperlipidemia and Diabetes Mellitus with Disease Outcomes in Amyotrophic Lateral Sclerosis
04:00 PM - 07:00 PM Abstract 050 - Differences in Initial Symptoms between Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS) in a Referral Centre
04:00 PM - 07:00 PM Abstract 051 - Building Web-Based Management Platform for Clinical Trials Networks in Neurology: Case Study in ALS
04:00 PM - 07:00 PM Abstract 052 - Possible Role of Familial, Environmental [amp] Occupational Risk Factors in Development of Amyotrophic Lateral Sclerosis: A Case Control Study
04:00 PM - 07:00 PM Abstract 053 - Smoking and the Risk of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
04:00 PM - 07:00 PM Abstract 054 - Smoking Is a Probable Risk Factor for ALS: An Evidence-Based Update (2003-2008)
04:00 PM - 07:00 PM Abstract 055 - Autosomal Dominant Motor Neuron Disease and Vermian Ataxia in a North American Family
04:00 PM - 07:00 PM Abstract 056 - Use of Capture-Recapture Methods To Estimate Amyotrophic Lateral Sclerosis Prevalence in Georgia
04:00 PM - 07:00 PM Abstract 058 - Specialist Care Patterns among Patients with Epilepsy in Rural Communities
04:00 PM - 07:00 PM Abstract 059 - Do Hippocampal FDG-PET Asymmetries Predict Post-Temporal Lobectomy Verbal Memory Dysfunction?
04:00 PM - 07:00 PM Abstract 060 - Cortical and Subcortical Contributions to Seizure Onset in Medication-Refractory Absence Seizures: EEG/fMRI Study
04:00 PM - 07:00 PM Abstract 061 - Predicting Epilepsy and Seizures from Vascular Risk Factors among the Elderly Patients
04:00 PM - 07:00 PM Abstract 062 - Clinical Correlates of White Matter Structural Integrity in Patients with Medically Refractory Epilepsy
04:00 PM - 07:00 PM Abstract 063 - Gene Expression Profile in Familial and Sporadic Forms of Mesial Temporal Lobe Epilepsy
04:00 PM - 07:00 PM Abstract 065 - An Efficient and Robust Method for the Fractional Anisotropy Analysis of White Matter Tracts Based on Automated Template Matching in Talairach Space
04:00 PM - 07:00 PM Abstract 066 - Material Specific Memory Impairment Is Associated with Unilateral Cingulum Bundle Structural Integrity in Intractable Temporal Lobe Epilepsy
04:00 PM - 07:00 PM Abstract 067 - Prevalence of Asymptomatic Intracranial Atherosclerosis in a Multi-Ethnic Population
04:00 PM - 07:00 PM Abstract 068 - Acute Stroke Care Capacity and Services in the Northwest United States, 2008: A Needs Assessment by the Northwest Regional Stroke Network (NWRSN)
04:00 PM - 07:00 PM Abstract 069 - Nationwide Factors Associated with Inadequate Blood Pressure Reduction among Stroke Survivors
04:00 PM - 07:00 PM Abstract 070 - Treatment of Dyslipidemia after Stroke: Analysis of a Nationwide Sample
04:00 PM - 07:00 PM Abstract 071 - Modifiable Behavioral Risk Factors in Stroke Survivors: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
04:00 PM - 07:00 PM Abstract 072 - Hospital Charges for Stroke Admissions Attributable to Racial Disparities in South Carolina during 2002-2006
04:00 PM - 07:00 PM Abstract 073 - Low Incidence of Stroke in Takayasu Arteritis. Long-Term Clinical Follow-Up
04:00 PM - 07:00 PM Abstract 074 - Ethnicity Is Not an Independent Predictor of Outcome after Treatment for Acute Ischemic Stroke
04:00 PM - 07:00 PM Abstract 075 - Trends in Hospitalization Rate, Hospital Case Fatality and Length of Stay for Stroke in Galicia (Spain), 1997-2007
04:00 PM - 07:00 PM Abstract 076 - Risk Factors Associated with Falling among Retirees with History of Stroke
04:00 PM - 07:00 PM Abstract 077 - Urine Toxicology Screening and Outcomes in an Urban Stroke Population
04:00 PM - 07:00 PM Abstract 078 - Increased US Utilization of Thrombolysis in the Treatment of Stroke
04:00 PM - 07:00 PM Abstract 079 - Glycosylated Hemoglobin Levels Correlate with Large- and Small-Artery Subtypes of Ischemic Stroke
04:00 PM - 07:00 PM Abstract 080 - Traumatic and Spontaneous Carotid and Vertebral Artery Dissection: A Level I Trauma Care Experience
04:00 PM - 07:00 PM Abstract 081 - Quality of Acute Ischemic Stroke Care among Senior Citizens. Results from the Argentinian Stroke Registry (ReNACer)
04:00 PM - 07:00 PM Abstract 082 - Racial Differences in Stroke Characteristics: A Retrospective Cohort and Imaging Study
04:00 PM - 07:00 PM Abstract 083 - Are 好色先生 and Socioeconomic Status Risk Factors for Mortality in Patients with Stroke and Transient Ischemic Attacks? Data from the NEDICES Study Group
04:00 PM - 07:00 PM Abstract 084 - Gender Differences in Blood Gene Expression during Ischemic Stroke
04:00 PM - 07:00 PM Abstract 085 - CADASIL: First Observation in Russia and Report of a New Mutation in the Notch3 Gene
04:00 PM - 07:00 PM Abstract 086 - CADASIL: Clinical Presentation in an Adolescent and Review of the Literature
04:00 PM - 07:00 PM Abstract 087 - Myopathies in the Elderly: A Hospital-Based Study
04:00 PM - 07:00 PM Abstract 088 - What Is the True Incidence and Prevalence of Myasthenia Gravis? A Systematic Review of Myasthenia Gravis Epidemiology
04:00 PM - 07:00 PM Abstract 089 - Nationwide Epidemiological Survey of Myasthenia Gravis in Japan
04:00 PM - 07:00 PM Abstract 090 - Frequency of False Positive Muscle Acetylcholine Receptor (AChR) Antibody Testing in Serological Evaluation for Neurological Autoimmunity
04:00 PM - 07:00 PM Abstract 091 - Quality of Life in Myasthenia Gravis
04:00 PM - 07:00 PM Abstract 092 - A Cooperative International Neuromuscular Research Group (CINRG) Study of the Relationship between Impairment, Activity Limitation, Participation and Quality of Life in Persons with Confirmed Dystrophinopathies: Methods and Baseline Characteristics
04:00 PM - 07:00 PM Abstract 093 - Nondystrophic Myotonias: Measuring Quality of Life in a Longitudinal Natural History Study
04:00 PM - 07:00 PM Abstract 094 - Mitochondrial Disease in Adult and Pediatric Patients with Fatigue and Myalgias
04:00 PM - 07:00 PM Abstract 095 - Registry of Outcome Measures (ROM) for Neuromuscular Trials
04:00 PM - 07:00 PM Abstract 096 - Regulatory NK Cells Mediate the Decreased Th17 Responses Associated with Abrogated New Disease Activity in MS Patients Treated with Bone Marrow Transplantation
04:00 PM - 07:00 PM Abstract 097 - Predictive Biomarkers of Clinical Response to Glatiramer Acetate (GA) Therapy in Multiple Sclerosis (MS)
04:00 PM - 07:00 PM Abstract 098 - Glatiramer Acetate-Induced Human Type II Monocytes Influence Differentiation of Na[iuml]ve T Cells
04:00 PM - 07:00 PM Abstract 099 - Multiple Sclerosis (MS): IFN[beta]-1b Induces Expression of Immunoinhibitory Immunoglobulin-Like Transcript 3 (ILT3) on Myeloid Cells
04:00 PM - 07:00 PM Abstract 100 - Impaired CD4+ T Effector: T Regulatory Cell Conversion in Relapsing Multiple Sclerosis: Reversal by Treatment with Glatiramer Acetate
04:00 PM - 07:00 PM Abstract 101 - Helminth Antigens Modulate Immune Responses in Multiple Sclerosis Patients by TLR2-Dependent Mechanisms
04:00 PM - 07:00 PM Abstract 102 - Assessment of a Possible Bioenergetic Marker of Cellular Immunocompetence in MS-Patients Undergoing Immunotherapy: Longitudinal Analyses
04:00 PM - 07:00 PM Abstract 103 - Pilot Study To Measure ATP Expression in Lymphocytes of MS Patients Undergoing Various Therapies Using the Cylex[trade] ImmuKnow[reg] Assay
04:00 PM - 07:00 PM Abstract 104 - T Cell Activation and Th2 Cytokine Secretion Correlate with Disease Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate
04:00 PM - 07:00 PM Abstract 105 - Cellular Expression of Genes Involved in Cladribine Metabolism
04:00 PM - 07:00 PM Abstract 106 - Autoantibodies to GAD and Cell Surface Determinants in Stiff Person Syndrome
04:00 PM - 07:00 PM Abstract 107 - Luteolin and Interferon-[beta] Modulate Immune Response(s) in Peripheral Blood Mononuclear Cells from Multiple Sclerosis Patients
04:00 PM - 07:00 PM Abstract 108 - Multiple Sclerosis: Glatiramer Acetate Differentially Regulates Monocytic Production of IL-1b and IL-1 Receptor Antagonist
04:00 PM - 07:00 PM Abstract 109 - Granzyme B Mediates T Cell-Induced Neurotoxicity through Cytoskeletal Disruption in Human Cortical Neurons
04:00 PM - 07:00 PM Abstract 110 - Low Production and Defective Regulation of Neurotrophins mRNA in Immune Cells of Patients with RR-MS
04:00 PM - 07:00 PM Abstract 111 - A Reverted Expression of Inflammation-Related Genes during Pregnancy Correlate with Decreased Disease Activity in Multiple Sclerosis: The GEXPRIMS Study
04:00 PM - 07:00 PM Abstract 112 - MBP-Specific Th17 Lymphocytes Selectively Increase during MS Relapses. A Multicenter Longitudinal Study
04:00 PM - 07:00 PM Abstract 113 - The Cytopathic Viral Effect (CPE) Assay in Sera of Naive Patients with Relapsing-Remitting Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 114 - Dimethyl Fumarate (BG00012) Inhibits Macrophage Inflammatory Activity In Vivo and In Vitro
04:00 PM - 07:00 PM Abstract 115 - A Dietary Pattern Protective Against Alzheimer's Disease (AD)
04:00 PM - 07:00 PM Abstract 116 - Physical Activity (PA) and Longevity in Alzheimer's Disease (AD)
04:00 PM - 07:00 PM Abstract 117 - Smoking in Midlife and Increased Risk of Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 118 - Body Mass Index and Cognitive Systems in Older Black and White Persons
04:00 PM - 07:00 PM Abstract 119 - Biomarker Screening for Alzheimer's Disease: The Impact of Sensitivity and Specificity Parameters
04:00 PM - 07:00 PM Abstract 120 - Correlates and Cognitive Decline Associated with White Matter Lesions Progression in the Elderly. The 3C-Dijon Study
04:00 PM - 07:00 PM Abstract 121 - Behavioral Disturbances in the Very Old with and without Dementia: The Monzino 80-Plus Population-Based Study
04:00 PM - 07:00 PM Abstract 122 - Lewy Body Dementia: The Caregiver Experience of Clinical Care
04:00 PM - 07:00 PM Abstract 123 - Low Walking Speed Is Associated with Increased Mortality and the Risk of Incident Dementia in Well-Functioning Elderly: The Three-City Study
04:00 PM - 07:00 PM Abstract 124 - Untreated Hypertension Is a Risk Factor for Senile Dementia. Data from the NEDICES Cohort Study
04:00 PM - 07:00 PM Abstract 125 - Long-Term Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Is Associated with Decreased Risk of All-Cause Dementia in the Oldest-Old: Results from The 90+ Study
04:00 PM - 07:00 PM Abstract 126 - Retinal Abnormalities and Cognitive Decline - The ARIC Study
04:00 PM - 07:00 PM Abstract 127 - Late-Life Orthostatic Hypotension and the Incidence of Clinical Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 128 - Metabolic Syndrome, Inflammation, and Mild Cognitive Impairment Subtypes in Elderly Persons: The Mayo Clinic Study of Aging
04:00 PM - 07:00 PM Abstract 129 - Compliance and Persistence of Oral Cholinesterase Inhibitors in Patients with Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 130 - Factors Associated with Nursing Home Placement in Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 131 - Age at Onset and Pre-Morbid IQ Influence Early Progression Rates in AD
04:00 PM - 07:00 PM Abstract 132 - Chronic Kidney Disease Is an Independent Risk Factor of Cerebral Atrophy
04:00 PM - 07:00 PM Abstract 133 - The Geographic Distribution of Alzheimer's Disease Mortality: Overlap with the US Stroke Belt
04:00 PM - 07:00 PM Abstract 134 - Clinical Dementia Is More Highly Associated with Braak Tangle Stage Than NIA-Reagan Criteria in the Oldest-Old
04:00 PM - 07:00 PM Abstract 135 - Late-Life Systolic Blood Pressure and the Incidence of Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 136 - Praying at Mid-Life Is Associated with Decreased Risk of Cognitive Decline in Women: A Door-to-Door Survey
04:00 PM - 07:00 PM Abstract 137 - Prediction of Medial Temporal Atrophy Scores in Cognitively Normal Subjects in the Florida ADRC
04:00 PM - 07:00 PM Abstract 138 - Refusal and Passive Loss-to-Follow-Up in the NIA Alzheimer's Disease Program Uniform Data Set
04:00 PM - 07:00 PM Abstract 139 - A Population Based Survey on Cognitive Performance in Sicily. Cognitive Impairment Is Modified in Women by Fertile Life Characteristics
04:00 PM - 07:00 PM Abstract 140 - Hypertension Increases the Probability of Alzheimer's Disease and of Being Cognitively Impaired Not Demented in Wadi Ara Villages: A Door-to-Door Population Study
04:00 PM - 07:00 PM Abstract 141 - Death in Newly Diagnosed Dementia
04:00 PM - 07:00 PM Abstract 142 - Motor Vehicle Crashes, Moving Violations, and Driving Cessation in Early Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 143 - Clinical and Neuropathological Features of Atypical FTLD-U
04:00 PM - 07:00 PM Abstract 144 - What's in a Naming Error?
04:00 PM - 07:00 PM Abstract 145 - What Causes Non-Fluent Speech in Progressive Non-Fluent Aphasia?
04:00 PM - 07:00 PM Abstract 146 - Apraxia of Speech Localizes to the Inferior Frontal Gyrus
04:00 PM - 07:00 PM Abstract 147 - Memantine and Constraint-Induced Aphasia Therapy in Chronic Post-Stroke Aphasia: A Randomized Controlled Trial with an Open-Label Extension Phase
04:00 PM - 07:00 PM Abstract 148 - Contributors to Naming Impairment in Corticobasal Syndrome
04:00 PM - 07:00 PM Abstract 149 - Novel Throwing Sign Discriminates Patients with Progressive Supranuclear Palsy
04:00 PM - 07:00 PM Abstract 150 - Progressive Logopenic Aphasia vs. Progressive Non-Fluent Aphasia: Clinical Differences and Progression
04:00 PM - 07:00 PM Abstract 151 - Cognitive and Neural Correlates of Written Language Impairment in Progressive Aphasia
04:00 PM - 07:00 PM Abstract 152 - Autonomic Nervous System and Aphasia
04:00 PM - 07:00 PM Abstract 153 - The Neuroanatomical Localization of Graphemic Buffer Deficits in Spelling
04:00 PM - 07:00 PM Abstract 154 - Non-Fluent Speech in Non-Fluent Progressive Aphasia and Logopenic Progressive Aphasia
04:00 PM - 07:00 PM Abstract 155 - Constructional Apraxia in Multiple Sclerosis
04:00 PM - 07:00 PM Abstract 156 - Analysis of Spelling and Written Grammar in Primary Progressive Aphasia Variants
04:00 PM - 07:00 PM Abstract 157 - Disruption of Grapheme-to-Phoneme Correspondence Mapping during Single Word Reading in Patients with Epilepsy: Implications for Models of Reading
04:00 PM - 07:00 PM Abstract 158 - Recurrent Epileptic Wernicke Aphasia
04:00 PM - 07:00 PM Abstract 159 - Clinical Dementia Rating for Primary Progressive Aphasia (CDR-ppa)
04:00 PM - 07:00 PM Abstract 160 - Using Category Fluency Data To Create Phylogenetic Trees of Cognitive-Phenotypes
04:00 PM - 07:00 PM Abstract 161 - Neuropsychiatric Symptoms in Primary Progressive Aphasia
04:00 PM - 07:00 PM Abstract 162 - Impaired Processing of Narratives in Parkinson's Disease
04:00 PM - 07:00 PM Abstract 163 - Clinical and Survival Profiles of Patients with Frontotemporal Dementia and Motor Neuron Disease
04:00 PM - 07:00 PM Abstract 164 - Insensitive to Hierarchy: ALS and FTD Display Overlapping Executive Impairment
04:00 PM - 07:00 PM Abstract 165 - Frontal Behavior: A Set of Factors, a Hierarchy of Symptoms, or Both?
04:00 PM - 07:00 PM Abstract 166 - Executive Function and Instrumental Activities of Daily Living in Aging and Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 167 - Comparison of Delayed Recall Tasks in a Memory Clinic
04:00 PM - 07:00 PM Abstract 168 - Clinical Diagnosis of Frontotemporal Dementia: Caveat Emptor
04:00 PM - 07:00 PM Abstract 169 - Quantitative and Qualitative Differences in Visual Confrontation Naming in Parkinson's Disease with and without Dementia and Alzheimer's Disease
04:00 PM - 07:00 PM Abstract 170 - Factors Contributing to Quantifier Comprehension in Corticobasal Syndrome
04:00 PM - 07:00 PM Abstract 171 - Computerized Visual Field Defects in Posterior Cortical Atrophy
04:00 PM - 07:00 PM Abstract 172 - Alien Limb Syndrome in a Left Handed Individual
04:00 PM - 07:00 PM Abstract 173 - Validation of the Cognitive Linguistic Quick Test with the Frontal Assessment Battery in PD
05:30 PM - 07:00 PM Break
Faculty Disclosures
Robert J. Adams, MD No disclosure on file
Martin L. Albert, MD, PhD No disclosure on file
Frederick Andermann, MD, FRCPC, FAAN No disclosure on file
David C. Anderson, MD, FAAN No disclosure on file
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Carmel Armon, MD, FAAN Dr. Armon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inbal - Israeli Government Insurance Company. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurological Sciences. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Individual attorney offices. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Civil Courts as a court-appointed expert. Dr. Armon has received publishing royalties from a publication relating to health care.
Barry G. Arnason, MD No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Origent. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Study section, DMC, NACA Council with NIH. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a invited lectures with AMCs. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a invited paper with National Academy of Sciences. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a lecture with National Academy of Neuropsychology.
Allan L. Bernstein, MD No disclosure on file
Thomas P. Bleck, MD, FAAN Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.
Kevin B. Boylan, MD No disclosure on file
Joseph P. Broderick, MD, FAAN Dr. Broderick has received publishing royalties from a publication relating to health care.
Ian J. Butler, MD No disclosure on file
Richard J. Caselli, MD, FAAN The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Suhayl S. Dhib-Jalbut, MD, FAAN No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Daniel A. Drubach, MD, FAAN No disclosure on file
Ranjan Duara, MD Dr. Duara has nothing to disclose.
Francois Dubeau, MD Dr. Dubeau has nothing to disclose.
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals.
David Eidelberg, MD, FAAN Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Christopher M. Filley, MD, FAAN Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
Julaine M. Florence Ms. Florence has nothing to disclose.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Robert P. Friedland, MD, FAAN No disclosure on file
Camilo R. Gomez, MD, FAAN Dr. Gomez has nothing to disclose.
Barry Gordon, MD, PhD, FAAN No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Jordan Grafman, PhD Dr. Grafman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Grafman has received research support from NIH. Dr. Grafman has received publishing royalties from a publication relating to health care.
Robert C. Griggs, MD, FAAN Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Mark Guttman, MD No disclosure on file
W. A. Hauser, MD, FAAN No disclosure on file
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Keith A. Johnson, MD Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervGen. An immediate family member of Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. The institution of Dr. Johnson has received research support from National Institute on Aging. The institution of an immediate family member of Dr. Johnson has received research support from Alzheimer's Association. The institution of an immediate family member of Dr. Johnson has received research support from Eli Lilly and Co. The institution of Dr. Johnson has received research support from Eisai. The institution of an immediate family member of Dr. Johnson has received research support from Eisai.
Lloyd H. Kasper, MD No disclosure on file
Michael D. Kaufman, MD No disclosure on file
Claudia Kawas, MD The institution of Dr. Kawas has received research support from NIH.
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Steven J. Kittner, MD, MPH The institution of Dr. Kittner has received research support from NINDS.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Robert T. Leshner, MD, FAAN No disclosure on file
James B. Leverenz, MD, FAAN Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
W. T. Longstreth, Jr., MD, FAAN The institution of Dr. Longstreth has received research support from NIH.
Demetrius M. Maraganore, MD, FAAN The institution of Dr. Maraganore has received research support from Agency for Healthcare Research and Quality. The institution of Dr. Maraganore has received research support from Florida Department of Health.
J R. McCarten, MD No disclosure on file
Leo McCluskey, MD No disclosure on file
Mario F. Mendez, MD, PhD, FAAN Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical 好色先生 Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
James A. Mortimer, PhD, FAAN No disclosure on file
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Yoshiko Nomura, MD, PhD No disclosure on file
John G. Nutt, MD, FAAN No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael D. Privitera, MD, FAAN Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK life science. Dr. Privitera has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK life science. Dr. Privitera has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Privitera has received research support from Neurelis. The institution of Dr. Privitera has received research support from Biohaven. Dr. Privitera has received research support from Neurava.
Steven Z. Rapcsak, MD No disclosure on file
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH.
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
A. D. Rothner, MD No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Ronald E. Saul, MD, FAAN No disclosure on file
Kathleen M. Shannon, MD, FAAN The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Frank R. Sharp, MD No disclosure on file
Eric R. Siemers, MD Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities.
Steven A. Sparr, MD, FAAN Dr. Sparr has nothing to disclose.
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
John Shoffner IV, MD No disclosure on file
Web Ross, MD The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Eric M. Wassermann, MD No disclosure on file
Maria V. Lopez-Bresnahan, MD, FAAN No disclosure on file
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Mary A. Picone, MD, FAAN No disclosure on file
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Luca Durelli, MD No disclosure on file
David J. Thurman, MD, FAAN No disclosure on file
Rivka Inzelberg, MD No disclosure on file
Jean Gotman, PhD No disclosure on file
Piero Verro, MD No disclosure on file
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
Jody Corey-Bloom, MD, PhD, FAAN Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.
Bernardino Ghetti, MD No disclosure on file
Sotirios A. Parashos, MD, PhD Dr. Parashos has received stock or an ownership interest from Abbott. Dr. Parashos has received research support from Park Nicollet Health Services. Dr. Parashos has received publishing royalties from a publication relating to health care.
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Susan D. Rountree, MD No disclosure on file
Panayiotis Mitsias, MD Dr. Mitsias has nothing to disclose.
Osvaldo Fustinoni, MD No disclosure on file
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
No disclosure on file
Reisa A. Sperling, MD Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nervgen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vaxxinity. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Sperling has received research support from Eli Lilly. The institution of Dr. Sperling has received research support from Eisai. The institution of Dr. Sperling has received research support from NIH.
Diana M. Escolar, MD, FAAN No disclosure on file
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Daniel Kaufer, MD, FAAN No disclosure on file
Stephen N. Scelsa, MD No disclosure on file
Amy R. Borenstein, PhD, FAAN No disclosure on file
Marie Vidailhet, MD, PhD No disclosure on file
Upinder K. Dhand, MD, FAAN No disclosure on file
Manuel Seijo-Martinez, MD, PhD, FAAN No disclosure on file
Lorene M. Nelson, PhD Dr. Nelson has nothing to disclose.
Giovanni Savettieri, MD No disclosure on file
Yutaka Tanaka, MD, FAAN No disclosure on file
Dale C. Hesdorffer No disclosure on file
Giancarlo Logroscino, MD, PhD, FAAN Dr. Logroscino has nothing to disclose.
Mustapha A. Danesi, MD No disclosure on file
Scott S. Zamvil, MD, PhD, FAAN Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Marian L. Evatt, MD, FAAN No disclosure on file
Ali Samii, MD, FRCP Dr. Samii has nothing to disclose.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Takashi Inuzuka, MD, FAAN No disclosure on file
John Van Swieten, MD Dr. Van Swieten has nothing to disclose.
Sophie Auriacombe Bergeaud, MD No disclosure on file
Jean-Francois Dartigues, PhD No disclosure on file
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Giuseppe Salemi, MD No disclosure on file
Richard Zweifler, MD, FAAN No disclosure on file
Mark E. Landau, MD, FAAN No disclosure on file
Lewis B. Morgenstern, MD, FAAN No disclosure on file
David L. Tirschwell, MD, FAAN Dr. Tirschwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CARMAT. Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Lindsay A. Farrer, MD No disclosure on file
Gene Y. Sung, MD, MPH The institution of Dr. Sung has received research support from NIH.
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Walter A. Kukull, PhD, FAAN The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Ricardo Nitrini, MD, FAAN No disclosure on file
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Daniel J. MacGowan, MD, FAAN No disclosure on file
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Paulo Caramelli, MD No disclosure on file
June Halper, RN, ANP Ms. Halper has nothing to disclose.
Francois Tison, MD, PhD No disclosure on file
Giovanni Piccolo, MD No disclosure on file
Vijay Dhawan, PhD No disclosure on file
Nicole Schupf, PhD, DrPH No disclosure on file
Youngsook Park, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Victoria S. Pelak, MD, FAAN Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.
Brad A. Racette, MD, FAAN Dr. Racette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for American Regent. Dr. Racette has received personal compensation in the range of $500-$4,999 for serving as a advisory council with NIEHS.
Alexander I. Troster, PhD Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Troster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cambridge University Press/International Neuropsychological Society. The institution of Dr. Troster has received research support from Barrow Neurological Foundation. Dr. Troster has received publishing royalties from a publication relating to health care.
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Nancy L. Sicotte, MD, FAAN The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Sergei N. Illarioshkin, MD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Freya Kamel, PhD No disclosure on file
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Emmanuelle Apartis, MD No disclosure on file
Marcelo Berthier Torres, MD No disclosure on file
Marcelo F. Rugiero, MD No disclosure on file
Pietro Pietrini, MD No disclosure on file
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Hiroaki Yoshikawa, MD No disclosure on file
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
David J. Libon, PhD No disclosure on file
Robert G. Smith, MD, PhD Dr. Smith has nothing to disclose.
David R. Renner, MD, FAAN Dr. Renner has nothing to disclose.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Zoe Arvanitakis, MD, MS, FAAN Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governement entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). The institution of Dr. Arvanitakis has received research support from Amylyx. The institution of Dr. Arvanitakis has received research support from Lilly. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
Amit Verma, MD, MBBS, FAAN No disclosure on file
Helen Petrovitch, MD No disclosure on file
Stephen K. Van Den Eeden, PhD Dr. Van Den Eeden has received personal compensation for serving as an employee of Kaiser Permanente Northern California. The institution of Dr. Van Den Eeden has received research support from NIH. The institution of Dr. Van Den Eeden has received research support from Biogen. The institution of Dr. Van Den Eeden has received research support from MJFF. The institution of an immediate family member of Dr. Van Den Eeden has received research support from NIH.
Arnon Karni, MD, PhD Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Karni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Prof. Karni has received research support from Medison. The institution of Prof. Karni has received research support from BMS. The institution of Prof. Karni has received research support from Novartis.
Bryan A. Bernard, PhD Dr. Bernard has nothing to disclose.
David J. Likosky, MD, SFHM, FAHA, FACP, FAAN No disclosure on file
Lon R. White, MD No disclosure on file
Kamal Masaki, MD No disclosure on file
Hiroyuki Murai, MD Dr. Murai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Murai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical. Dr. Murai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Murai has received research support from Japan Blood Products Organization.
Paul J. Massman, PhD No disclosure on file
Hanns Lochmuller, MD, FAAN Dr. Lochmuller has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Antonio Uccelli, MD An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Todd L. Richards, PhD No disclosure on file
Michael R. Rose, MD No disclosure on file
Amir M. Arain, MD, FAAN Dr. Arain has nothing to disclose.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Neil R. Friedman, MD, MBChB No disclosure on file
Cyrus P. Zabetian, MD The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Suzanne R. Lesage, MD No disclosure on file
Gustavo Saposnik, MD Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Lucas Restrepo, MD, PhD Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Roberto Sica, MD, PhD No disclosure on file
Nicholas Okon, DO No disclosure on file
John E. Duda, MD Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Angela Vincent, MBBS, MSc Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Angela Vincent, MBBS,MSc has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care. Angela Vincent, MBBS,MSc has received intellectual property interests from a discovery or technology relating to health care.
Piu Chan, MD, PhD No disclosure on file
Carlo Colosimo, MD No disclosure on file
Maja Relja, MD No disclosure on file
Maria Corrada, PhD The institution of Dr. Corrada has received research support from NIH.
Jane S. Paulsen, PhD Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for INmune Bio. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lily. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation for serving as an employee of Argenx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Inc. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ABPN.
Pradumna Singh, MD No disclosure on file
Victoria Lawson, MD, FAAN Dr. Lawson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Alexandre Prat, MD The institution of Dr. Prat has received research support from CIHR and MSSC.
Eliane Kobayashi, MD, PhD Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Knight pharmaceuticals. Dr. Kobayashi has received personal compensation in the range of $0-$499 for serving as a Consultant for Creative Research Designs. Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmacuticals. Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Laboratories. Dr. Kobayashi has received personal compensation in the range of $0-$499 for serving as a author with Medlink .
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Guerry M. Peavy, PhD Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH.
Julie A. Fields, BA No disclosure on file
Jan P. Larsen No disclosure on file
Felix Bermejo-Pareja, MD No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Ugo Nocentini No disclosure on file
Catherine L. Wielinski, MPH No disclosure on file
Jill R. Murrell, PhD No disclosure on file
Julian Benito-Leon No disclosure on file
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Lesley K. Fellows, MD, DPhil No disclosure on file
Felicia B. Axelrod, MD No disclosure on file
Jyh-Gong G. Hou, MD, PhD, FAAN No disclosure on file
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Shannon Venance, MD, PhD No disclosure on file
Anand Vaishnav, MD No disclosure on file
Luc Taillandier, MD No disclosure on file
Christine Tranchant, MD No disclosure on file
Dorene M. Rentz, PsyD Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Digital Cognition Technologies. Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurotrack.
Kenneth Wagner, PhD No disclosure on file
Andrew H. Chan, MD No disclosure on file
Carlos Cantu, MD, MSc Dr. Cantu has nothing to disclose.
Mauro Zaffaroni No disclosure on file
Susan E. Goelz, PhD No disclosure on file
Alexis Elbaz, MD No disclosure on file
Ole-Bjorn Tysnes No disclosure on file
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Pietro Tiraboschi, MD No disclosure on file
Monica Brendsrud No disclosure on file
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Aurelio Mendez-Dominguez, MD Dr. Mendez-Dominguez has nothing to disclose.
Osheik A. Seidi, MD, FRCP, CCST,FAAN, FAAN Dr. Seidi has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Louisa Kalsner, MD No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
David A. Brenner, MD No disclosure on file
Mark W. Jacobson, PhD No disclosure on file
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Michel Baulac, MD No disclosure on file
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Netta Levin, MD, PhD Dr. Levin has nothing to disclose.
Andreas R. Luft, MD No disclosure on file
Sue M. Lai, PhD No disclosure on file
Nerses Sanossian, MD, FAAN Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Kamakshi Lakshminarayan, MD, PhD Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Bryan K. Woodruff, MD The institution of Dr. Woodruff has received research support from National Institute on Aging.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Kinga Szigeti, MD, PhD No disclosure on file
Jin Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
Glen R. Finney, MD, FAAN Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities.
Dana F. Boatman No disclosure on file
Marco Capobianco, MD No disclosure on file
Jun-ichi Kira, MD, PhD Dr. Kira has nothing to disclose.
Philippe Coubes, PhD No disclosure on file
Marco D'Amelio, MD No disclosure on file
Ayse Sagduyu No disclosure on file
Egon Stenager, MD No disclosure on file
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jyoti Pillai, MD, MBBS, MR, FAAN Dr. Pillai has a non-compensated relationship as a President with Pennsylvania Neurological Association that is relevant to AAN interests or activities.
Jennifer J. Majersik, MD, FAAN Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Yunxia Wang, MD, FAAN Dr. Wang has nothing to disclose.
Carole Dufouil, PhD No disclosure on file
Scott Shulman, MD No disclosure on file
Alexandros L. Georgiadis, MD No disclosure on file
Dag Aarsland, MD No disclosure on file
Andres M. Villa, MD Dr. Villa has nothing to disclose.
Alberto Ascherio, MD, PhD The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Jean A. Jaglin, RN No disclosure on file
Thomas H. Mosley, PhD No disclosure on file
Peachie N. Moore, BA No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Giovanni Antonini No disclosure on file
Michel Chofflon, MD No disclosure on file
Leslie E. Phillips, BA No disclosure on file
Erik K. Henricson, MPH No disclosure on file
Miia Kivipelto, MD No disclosure on file
Samay Jain, MD No disclosure on file
Simona Malucchi No disclosure on file
William D. Freeman, MD, FAAN Dr. Freeman has nothing to disclose.
Rebecca F. Gottesman, MD The institution of Dr. Gottesman has received research support from NIH.
Kevin A. Kerber, MD Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for McBride Hall Attorneys . The institution of Dr. Kerber has received research support from National Institutes of Health. Dr. Kerber has received publishing royalties from a publication relating to health care.
Gad Marshall, MD Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma USA Inc. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beth Israel Deaconness Medical Center. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publications.
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Elijah Chaila, MD No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Cornelia Laule, PhD The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Fabrizio Giuliani, MD No disclosure on file
Luca Roccatagliata, MD No disclosure on file
Alessia Di Sapio, MD No disclosure on file
Brandon R. Barton, MD, FAAN Dr. Barton has nothing to disclose.
Aleksandar Videnovic, MD, MSc, FAAN Dr. Videnovic has nothing to disclose.
Andrew Russman, DO, FAAN Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Amie L. Hiller, MD The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Sang B. Jeon, MD No disclosure on file
Rachel Whitmer, PhD Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech . Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's and Dementia:Journal of the Alzheimer's Association . The institution of Dr. Whitmer has received research support from National. Institute of Health .
Beth Leeman-Markowski, MD, MA, MMSc Dr. Leeman-Markowski has received research support from FACES Foundation. Dr. Leeman-Markowski has received research support from Veterans Administration - CSRD Career Development Award-2.
Robert D. Abbott, PhD No disclosure on file
Helenius J. Schelhaas, MD No disclosure on file
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Paul Nietert No disclosure on file
Guido Alves No disclosure on file
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Mark A. Jensen, PhD No disclosure on file
Shawn Smyth, MD Dr. Smyth has nothing to disclose.
Allison Wright Willis, MD Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Nikolaus McFarland, MD, PhD, FAAN Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceuticals. Dr. McFarland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. McFarland has received research support from NIH, Michael J. Fox Foundation, Huntington Disease Society for America, CurePSP, and Mission MSA.. Dr. McFarland has received publishing royalties from a publication relating to health care.
Kathleen Poston, MD, FAAN Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Amy T. Towfighi, MD Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH.
Suresh Kumar, MD Dr. Kumar has nothing to disclose.
Alberto Maud, MD Dr. Maud has nothing to disclose.
Angelos Katramados, MD Dr. Katramados has nothing to disclose.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Winnie C. Pao, MD No disclosure on file
David Hojnacki, MD, FAAN Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Daniel Antoniello, MD Dr. Antoniello has nothing to disclose.
Valerie McGuire, PhD No disclosure on file
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Marc Weisskopf, PhD Dr. Weisskopf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Weisskopf has received research support from Biogen. The institution of Dr. Weisskopf has received research support from NIH.
Richard Abresch No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Jacqueline Chen No disclosure on file
Brigette Biolsi No disclosure on file
Kassandra L. Munger Ms. Munger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ms. Munger has received research support from Department of Defense.
Sergio Baranzini Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Salah Foundation. The institution of Sergio Baranzini has received research support from NIH. The institution of Sergio Baranzini has received research support from NSF. Sergio Baranzini has received intellectual property interests from a discovery or technology relating to health care. Sergio Baranzini has a non-compensated relationship as a co-funder with Mate Bioservices that is relevant to AAN interests or activities.
Martin Weber, MD Dr. Weber has nothing to disclose.
Peter Hannon, MD, FAAN Dr. Hannon has nothing to disclose.
Patricia Garcia, DO No disclosure on file
Octavian R. Adam, MD The institution of Dr. Adam has received research support from Jazz Pharmaceutical. The institution of Dr. Adam has received research support from Sage Therapeutics. The institution of Dr. Adam has received research support from Abbott Laboratories.
Sarah Kremen, MD Dr. Kremen has received publishing royalties from a publication relating to health care.
J. Douglas Miles, MD, PhD, FAAN Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Charles Shyu, MD No disclosure on file
Simon Cronin, PhD Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Glen Jickling, MD No disclosure on file
Valory Pavlik, PhD The institution of Dr. Pavlik has received research support from Alzheimer's Association.
Christian Wider, MD No disclosure on file
Fizel A. Al-Himyari, MD No disclosure on file
Brandon R. Grossardt, MS No disclosure on file
Stephanie Cosentino, PhD Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for Frontotemporal Dementia. Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAGE Pharmaceuticals.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Rosebud O. Roberts, MD No disclosure on file
Valentina Torri Clerici Valentina Torri Clerici has nothing to disclose.
Reuben M. Valenzuela, MD No disclosure on file
Dominick Paes No disclosure on file
Zohara Sternberg, PhD No disclosure on file
Fernando Taragano No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Eleonora Tavazzi, MD No disclosure on file
Yilong Ma, PhD The institution of Dr. Ma has received research support from AskBio. The institution of Dr. Ma has received research support from Aspen Neuroscience . The institution of Dr. Ma has received research support from Blue Rock . The institution of Dr. Ma has received research support from Bayer.
Carla Stefani, MD No disclosure on file
Cecilia Serrano No disclosure on file
Chiara Fenoglio, PhD No disclosure on file
Luciano Rinaldi No disclosure on file
Christophe Tzourio, MD, PhD No disclosure on file
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Edward C. Jauch, MD, MS, FAHA, FACEP No disclosure on file
Thomas Koepsell No disclosure on file
Howard Aizenstein, MD, PhD No disclosure on file
Julien Dumurgier No disclosure on file
Jacqueline Channon-Smith No disclosure on file
James M. Gee No disclosure on file
Ling Zheng, MBBS, PhD No disclosure on file
Lisa L. Barnes Lisa L. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. The institution of Lisa L. Barnes has received research support from NIH. Lisa L. Barnes has received personal compensation in the range of $500-$4,999 for serving as a Council member with NACMHD.
Sharon Ash No disclosure on file
Paola Cavalla No disclosure on file
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Rachel Goldmann Gross, MD No disclosure on file
Francesca Gilli No disclosure on file
Robert Weissert, MD, FAAN No disclosure on file
Yusuke Nanri, MD No disclosure on file
Kristin Kahle-Wrobleski No disclosure on file
Caterina Rosano, MD, MPH No disclosure on file
Yuji Tanaka, MD, PhD No disclosure on file
Ana Laura Cif, MD No disclosure on file
Raphael Hourez, MD, PhD No disclosure on file
Claudia V. Maurer-Morelli, PhD No disclosure on file
Niall Tubridy, MD Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Francesca Brett No disclosure on file
Angelia Paschal No disclosure on file
Craig A. Molgaard, PhD, MPH No disclosure on file
Thomas E. Prod'Homme, PhD No disclosure on file
Yi Wang, PhD Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Paolo Ragonese No disclosure on file
Ophelia Godin No disclosure on file
Evan Thacker, PhD The institution of Evan Thacker, PhD has received research support from NIH.
Cindy Nowinski, MD PhD The institution of Dr. Nowinski has received research support from National Institutes of Health.
Chris Tang, MD No disclosure on file
Salvatore Spina, MD Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acsel Health. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Xtract. Dr. Spina has received research support from Tau Consortium. Dr. Spina has received research support from Chan Zuckerberg Initiative, LLC. Dr. Spina has received research support from Bluefield Project to Cure FTD.
Sergey A. Klyushnikov, MD No disclosure on file
Gabriel Rodriguez, MD No disclosure on file
Adolfo Minguez Castellano, MD No disclosure on file
Ana Maria Garcia Medina, MD No disclosure on file
Peter Adamczyk, MD No disclosure on file
James F. Morley, MD, PhD Dr. Morley has nothing to disclose.
Enrique Diaz No disclosure on file
Daniela Perani, MD No disclosure on file
Normand E. Allaire No disclosure on file
Daniel J. Berlau, PhD No disclosure on file
Cristobal Carnero-Pardo No disclosure on file
David Cella, PhD No disclosure on file
Catalina Cleves, MD Dr. Cleves has nothing to disclose.
Giulia Contessa No disclosure on file
Cameron Davis, MS No disclosure on file
Shirin Issa, MD No disclosure on file
Pue Farooque, DO No disclosure on file
Cordelia Erickson-Davis No disclosure on file
Mei-Sheng Duh, MPH, ScD No disclosure on file
Domingo O. Garcea, MD No disclosure on file
Leonid Gorelik, PhD No disclosure on file
Maria T. Greig Custo No disclosure on file
Laura S. Hemmy, PhD No disclosure on file
Mohammad Ikram The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Vijay Kannan No disclosure on file
Jason H. Karlawish, MD No disclosure on file
Virginia Lee, PhD Virginia Lee, PhD has nothing to disclose.
Adar Kravitz No disclosure on file
Christopher Leibman No disclosure on file
Pauline Maillard, PhD No disclosure on file
Chetan Soni, MD No disclosure on file
Rosa Rademakers, PhD Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Cristina Montomoli No disclosure on file
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Tahir Shaikh No disclosure on file
Alexander Sherman The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Sheng-Han Kuo, MD, FAAN Dr. Kuo has nothing to disclose.
Reza Seyedsadjadi, MD Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Jessica McFarlin, MD Dr. McFarlin has received personal compensation in the range of $500-$4,999 for serving as a Volunteer Faculty with Vital Talk.
Munish K. Goyal, MD, FAAN No disclosure on file
Wayne W. Feng, MD, FAAN Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Turi Dalaker No disclosure on file
Kamalesh Das, MD No disclosure on file
Aisling Carr, MD No disclosure on file
Ugonma N. Chukwueke, MD Dr. Chukwueke has nothing to disclose.
Elfatih Ali, MD No disclosure on file
Alvaro Alonso No disclosure on file
Allison Drake No disclosure on file
Edo Bottacchi No disclosure on file
Fang Fang No disclosure on file
Christine Farag No disclosure on file
Lama Fawaz, PhD No disclosure on file
Gisella Gargiulo Monachelli, MD, PhD No disclosure on file
Lauren C. Hyams, PhD No disclosure on file
Christof Karmonik, PhD No disclosure on file
Hania Kebir, PhD Ms. Kebir has received research support from Fonds de Recherche du Québec-Santé. Ms. Kebir has received intellectual property interests from a discovery or technology relating to health care.
Genevieve Langley No disclosure on file
Dan Hesse No disclosure on file
Yosr Hizem No disclosure on file
Bagar A. Husaini No disclosure on file
Raffaella Migliaccio Raffaella Migliaccio has nothing to disclose.
Biggya Sapkota, MBBS No disclosure on file
Elizabeth Potter, DO, PhD No disclosure on file
Camila Pupe, MD Dr. Pupe has nothing to disclose.
Galeno Rojas, MD No disclosure on file
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Sarah Ryan No disclosure on file
Harro Seelaar, MD, PhD Dr. Seelaar has nothing to disclose.
Yusuke Yakushiji, MD, PhD No disclosure on file
Adriana M. Strutt, PhD No disclosure on file
M. Maria Glymour, PhD No disclosure on file
Weiyi Gao, MD No disclosure on file
Dalia Rotstein, MD Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from CMSC. The institution of Dr. Rotstein has received research support from Roche Canada. Dr. Rotstein has received research support from National MS Society.
Xiaojun You, PhD No disclosure on file
Nikita Mody-Patel No disclosure on file
Aurelie Ruet The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme.
Paul Eugene P. Lleva, MD, FAAN Dr. Lleva has nothing to disclose.
Thanh Ton, PhD No disclosure on file
Chafic Y. Karam, MD Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm.
Andres F. Deik Acosta Madiedo, MD, FAAN Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care.
Kinshuk Sahaya, MD, FAES, FAAN Dr. Sahaya has nothing to disclose.
Metha Apiwattanakul, MD Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for teva. Dr. Apiwattanakul has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Maralyssa Bann No disclosure on file
Matthew P. Bussa, MPH No disclosure on file
Pradeep Bista No disclosure on file
Qiao Ling Cui, MD No disclosure on file
Peter Darlington, PhD No disclosure on file
Manuela De Stefano No disclosure on file
Beatriz Espejo Martinez, MD Beatriz Espejo Martinez, MD has nothing to disclose.
Claire Ewenczyk No disclosure on file
A. Mark Fendrick No disclosure on file
Mario F. Dulay, PhD No disclosure on file
Chara Chamie No disclosure on file
Kasey L. Gildersleeve, MD No disclosure on file
Thashi Chang, MD, FRCP, DPhil No disclosure on file
Neil Chawla No disclosure on file
Zhuqin Gu No disclosure on file
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Lakevia Hall No disclosure on file
Victoria Gonzalez Martinez, MD No disclosure on file
Jay Han, MD No disclosure on file
Jesia Hasan No disclosure on file
Jay M. Margolis No disclosure on file
Maya L. Henry, PhD No disclosure on file
Simon Israeli-Korn, MD No disclosure on file
Brianna Morgan No disclosure on file
Lisa Mucha, PhD No disclosure on file
Oleg Muravov No disclosure on file
Nawaf H. Murshed, MD No disclosure on file
Wendy E. Kaye, PhD Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Marianne Kearney No disclosure on file
Trent P. McLaughlin, PhD No disclosure on file
Silvia Messina No disclosure on file
Mauricio F. Farez, MD Dr. Farez has nothing to disclose.
Derek Pappas, PhD No disclosure on file
Minna Rusanen No disclosure on file
Priscilla C. Russo No disclosure on file
Helle B. Sondergaard, PhD Dr. Sondergaard has nothing to disclose.
Wendy A. Shultis No disclosure on file
Brij M. Singh Ahluwalia No disclosure on file
Yoshiki Takai, MD No disclosure on file
Florian Perez No disclosure on file
Collin M. Spencer No disclosure on file
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Joanne M. Auld No disclosure on file
Nicola Ticozzi, MD The institution of Dr. Ticozzi has received research support from Italian Ministry of Health . The institution of Dr. Ticozzi has received research support from AriSLA.
Michael Wittie No disclosure on file
Kerry Ledoux No disclosure on file
Haralabos Zacharatos, MD Dr. Zacharatos has nothing to disclose.
Kurt E. Weaver, PhD No disclosure on file
Bogachan Sahin, MD No disclosure on file
Matthias Schwab, PhD No disclosure on file
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Alexandra J. Sequeira, MD Dr. Sequeira has nothing to disclose.
Jeanie C. McGee, DHEd, NSHS, CCRC No disclosure on file
Katy Eichinger, PhD, PT, DPT, NCS Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Vishal Jani, MD Dr. Jani has nothing to disclose.
Alissa A. Thomas, MD, FAAN The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Leonard L. Yeo, MBBS The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Maryam Nabavi Nouri, MD Dr. Nabavi Nouri has nothing to disclose.
Chris Hackett, MA Mr. Hackett has nothing to disclose.
Melih Tutuncu, MD No disclosure on file
Jaswinder P. Singh, MD No disclosure on file
Hanna Czarkowska, MD No disclosure on file
Rizwan Kalani, MD The institution of Dr. Kalani has received research support from NIH.
Jonathan J. Ong, MD No disclosure on file
Ahmed H. Althobaiti, MD No disclosure on file
Maria Ernestina Moreira Santos, MD No disclosure on file
Carmen Tur Gomez, MD No disclosure on file
Cerqua Raffaella No disclosure on file
Nicholas T. Olney, MD No disclosure on file
Janet Elgallab, MD No disclosure on file
Christopher Olm No disclosure on file
Eduardo R. Davidovich Dr. Davidovich has nothing to disclose.
Jenifer Voeks Jenifer Voeks has nothing to disclose.
Diogo Amarante, MD No disclosure on file
Steven O'Donnell, MD No disclosure on file
Olubunmi Omojowolo, MD No disclosure on file
Lucido L. Ponce Mejia, MD No disclosure on file
Deepak K. Gupta, MBBS The institution of Dr. Gupta has received research support from Department of Defense.
Nuala McNicholas, MBBS Dr. McNicholas has nothing to disclose.
Eugene L. Scharf, MD The institution of Dr. Scharf has received research support from American Brain Foundation. The institution of Dr. Scharf has received research support from NIH. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Grand Rounds. Dr. Scharf has a non-compensated relationship as a Steering committee with Johnson and Johnson that is relevant to AAN interests or activities.
Miriam S. Welgampola, MD Dr. Welgampola has nothing to disclose.
Eileen Moran, MD No disclosure on file
Christine R. Swanson, PhD No disclosure on file
Gloria Kim No disclosure on file
Habib Bousleiman, PhD No disclosure on file
Joseph Posner No disclosure on file
Michael Auer Michael Auer has nothing to disclose.
Rhonda Friedman, PhD No disclosure on file
Samuel J. Cohn, MD No disclosure on file
Siw Johannesen, MD No disclosure on file
Yosef Berlyand No disclosure on file
Camilo Diaz-Cruz, MD Dr. Diaz-Cruz has nothing to disclose.
GURCHARANJEET KAUR, MBBS Dr. Kaur has nothing to disclose.
Luis F. Tornes, MD Dr. Tornes has nothing to disclose.
Nina A. Fainberg No disclosure on file
Venugopalan Y. Vishnu, MD The institution of Dr. Vishnu has received research support from Department of Health Research.
Santina Cutrupi No disclosure on file
Yi Shiau Ng No disclosure on file
Menorca Chaturvedi No disclosure on file
Nuria Carrillo, MD No disclosure on file
Mark D. Skopin No disclosure on file
Saul Reyes, MD Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
John Ko, PharmD, MS Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Gabriel Bsteh, MD Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene-BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme.
Benjamin Stewart, MD No disclosure on file
Silvia Basaia Silvia Basaia has nothing to disclose.
Andreas Dammann Andersen No disclosure on file
Robert Field, MBBS, PhD No disclosure on file
Rosanne Govaarts, MSc Ms. Govaarts has nothing to disclose.
Rens Hanewinckel, MD, PhD No disclosure on file
Ameera Haque No disclosure on file
Sanne Hobbelink No disclosure on file
Jeffrey Dawson Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Leonardo Almeida No disclosure on file
Carl Langefeld No disclosure on file
Letizia Mazzini No disclosure on file
Patrick Lefebvre No disclosure on file
Manish Modi No disclosure on file
Jose Luchsinger-Stuart No disclosure on file
Andrea Falini No disclosure on file
Amy Wang No disclosure on file